Stenocare A/S
CPH: STENO.CO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Copenhagen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Thomas Skovlund Schnegelsberg
- Employees
- 8
- Headquarters
- Randers, Denmark
- IPO year
- 2020
- Market cap
- DKK 52.5M
- Website
- https://stenocare.dk
Loading STENO…
Loading profile data…Frequently asked questions about STENO
What does Stenocare A/S (STENO.CO) do?
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Where does STENO.CO trade?
Stenocare A/S (STENO.CO) trades on the NASDAQ Copenhagen.
What sector is STENO.CO in?
Stenocare A/S (STENO.CO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Stenocare A/S?
Thomas Skovlund Schnegelsberg is the chief executive officer of Stenocare A/S (STENO.CO).
Where is Stenocare A/S headquartered?
Stenocare A/S is headquartered in Denmark.
Does STENO.CO pay a dividend?
Stenocare A/S (STENO.CO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STENO.CO go public?
Stenocare A/S (STENO.CO) completed its initial public offering in 2020.